Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

60¼¼ À̻󿡼­ ¿¬·ÉƯÀÌÀû Àü¸³¼±Æ¯ÀÌÇ׿ø Âü°íÄ¡ÀÇ Àû¿ëÀ¸·Î °£°úµÇ´Â Á¾¾çÀÇ º´¸®ÇÐÀû Ư¼º Pathologic Characteristics of Prostate Cancers Missed by Application of the Age-specific Prostate-specific Antigen Reference in Men over Sixties

´ëÇѺñ´¢±â°úÇÐȸÁö 2007³â 48±Ç 8È£ p.809 ~ 814
Á¤¼ºÁø, ÇÑÁØÇö, ÀåÀÎÈ£, À¯ÁöÇü, ÇѺ´±Ô, È«¼º±Ô, º¯¼®¼ö, ÀÌ»óÀº,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤¼ºÁø ( Jeong Seong-Jin ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú

ÇÑÁØÇö ( Han Jun-Hyun ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú
ÀåÀÎÈ£ ( Chang In-Ho ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú
À¯ÁöÇü ( Yu Ji-Hyeong ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú
ÇѺ´±Ô ( Han Byoung-Kyu ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú
È«¼º±Ô ( Hong Sung-Kyu ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú
º¯¼®¼ö ( Byun Seok-Soo ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú
ÀÌ»óÀº ( Lee Sang-Eun ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú

Abstract


Purpose: To examine the pathologic characteristics of prostate cancers missed by application of the age-specific prostate-specific antigen(PSA) reference in Korean men over sixties in clinical practice based on PSA cutoff 3.0ng/ml.
Materials and Methods: We made retrospective analysis of 1,063 patients aged between 60-79 who had had transrectal ultrasonography(TRUS)- guided biopsy due to the rise of PSA over 3.0ng/ml or abnormal findings in digital rectal examination(DRE) or TRUS. Age-specific PSA reference was set at 3.9ng/ml for 60s and 5.4ng/ml for 70s.

Results: Prostate cancer was detected in 34.3%(365/1,063) as a whole, and 31.5% in 60s, and 39.5% in 70s according to the age. When age-specific reference 3.9ng/ml was applied to 60s, 20(9.6%) cancers were missed compared with clinical cutoff value(3.0ng/ml). When age-specific reference 5.4ng/ml was applied to 70s, 23(16.0%) cancers were missed. On the average, 43(12.2%) of cancers were missed in 60s and 70s. Of 43 missed cancers, 39(90.7%) were with normal DRE and TRUS. Of these cancers, 16(41.0%) were clinically insignificant on biopsy, but only 7(22.6%) were insignificant in the pathologic examination of 31 radical prostatectomy specimens.

Conclusions: In our clinical practice based on PSA cutoff 3.0ng/ml, most cancers missed by application of age-specific reference are clinically significant. But, considering the positive effect of age-specific reference on avoidance of unnecessary biopsies, large prospective study is needed to evaluate the efficacy of age-specific reference in Korean men over sixties.

Å°¿öµå

Prostate cancer; Prostate-specific antigen; Age

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS